Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era

Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era

Nicola Squillace,1 Giorgio Bozzi,2 Elisa Colella,1 Andrea Gori,2 Alessandra Bandera1 1Infectious Diseases Unit, Azienda Socio Sanitaria Territoriale di Monza, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy; 2Infectious Disease Unit, Department of Internal Medicine, Fondazione IRCC...

Full description

Bibliographic Details
Main Authors: Squillace N, Bozzi G, Colella E, Gori A, Bandera A
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Drug Design, Development and Therapy
Subjects:
Protease inhibitors
darunavir/cobicistat
emtricitabine/tenofovir alafenamide
HIV
Online Access:https://www.dovepress.com/darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-safety-and-ef-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-safety-and-ef-peer-reviewed-article-DDDT

Similar Items